Discover the latest updates on the ongoing novel coronavirus outbreak in the ‘COVID-19 Hub’, powered by Infectious Diseases Hub and our partner journals and eCommunities across the Future Science Group family.
The COVID-19 outbreak has rapidly swept the world since first being reported in December 2019, leading to an ever-increasing number of cases and deaths, severe pressure on health services across the globe, and unprecedented restrictions on movement, transport, business and education.
Here, you can discover the latest news headlines and daily updates, and also read more in-depth articles on the pandemic collated from across the Future Science Group journals and eCommunities: all content is fully open-access and free to read, and will be updated daily.
Want to stay updated? Receive the latest news direct to your inbox by becoming a member: register for free here.
Latest coronavirus news – updated daily
News stories from this week:
- COVID-19: vaccine and drug development updates (BioTechniques)
- Life sciences companies enter international partnership to develop and manufacture rapid test for COVID-19 (Bioanalysis Zone)
- MERS vaccine success in mice suggests potential for COVID-19 vaccine development (ID Hub)
- From bats to big cats: how are animals affected by COVID-19? (BioTechniques)
- COVID-19: experts suggest updated treatment guidelines for bowel cancer (Oncology Central)
- Insight into SARS-CoV-2 genome spells good news for vaccine development (BioTechniques)
- Trial drug against COVID-19 shows promise in engineered human tissues (ID Hub)
- Could tocilizumab reduce COVID-19 symptoms for blood cancer patients? (Oncology Central)
- 3D printing in a time of coronavirus: the additive response to COVID-19 (3DMedNet)
- COVID-19 vaccine candidate shows promise in preclinical research (ID Hub)
- Man’s best friend to the rescue! Dogs could be taught to ‘sniff out’ coronavirus (BioTechniques)
- COVID-19: how can we prevent SARS-CoV-2 infection in cancer patients? (Oncology Central)
- International community generating real-world evidence on COVID-19 (The Evidence Base)
- Studies to investigate protective effects of hydroxychloroquine against COVID-19 for healthcare workers (The Evidence Base)
- Thousands of coronavirus cases prevented by China’s control interventions, analysis suggests (ID Hub)
- COVID-19: latest news and updates (BioTechniques)
- Could artificial intelligence be the key to fighting coronavirus? (BioTechniques)
- New registry launched to collect and share data on how COVID-19 affects individuals with rheumatic diseases (The Evidence Base)
- Improved COVID-19 symptom-tracking app recruiting users across the USA (The Evidence Base)
- Pangolins: the missing link in coronavirus transmission? (ID Hub)
- COVID-19 diagnostic test enters validation process (Bioanalysis Zone)
- COVID-19: do cancer patients have a higher risk of infection? (Oncology Central)
- Nanovaccines could provide the key to fighting today’s deadliest viruses (The Nanomed Zone)
- Real-time symptom-tracking app launched to curtail COVID-19 spread (The Evidence Base)
- FDA promotes expanded use of remote health monitoring devices, to limit in-person patient—provider contact during the COVID-19 outbreak (The Evidence Base)
- COVID-19 monitoring program launched by PRA Health Sciences (Bioanalysis Zone)
- Mobile health platform could improve clinical trial support during COVID-19 pandemic (Bioanalysis Zone)
- Coronavirus: continued updates in basic research, vaccine development and testing (BioTechniques)
- COVID-19 monitoring program launched by PRA Health Sciences (Bioanalysis Zone)
- ‘Highly Relevant’ cell therapy for acute corona-related respiratory distress (RegMedNet)
- COVID-19: borders and businesses close across Europe (ID Hub)
- Could a mobile app for contact tracing help in the fight against COVID-19? (The Evidence Base)
- COVID-19: First patients dosed in Phase I vaccine trial (ID Hub)
- Update: First patients dosed with COVID-19 nanovaccine in Phase 1 trial (The Nanomed Zone)
- Coronavirus: sorting the fact from the fiction (BioTechniques)
- Innovative nanofiber filter could be vital in the development of face masks and respirators (BioTechniques)
- 3D-printed valves supply unmanageable demand for essential ventilator equipment (3DMedNet)
- A unique solution for ‘containment’: Materialise releases minimum-contact door handle (3DMedNet)
- Collaborative teams solves PPE shortage issue: 3D-printed facemasks and screens for healthcare workers in Hong Kong (3DMedNet)
- When industries unite: how 3D-printed ‘huts’ serve as emergency quarantine wards (3DMedNet)
- FDA issue emergency use authorization to Thermo Fisher Scientific for COVID-19 diagnostic test (Bioanalysis Zone)
- US FDA grants further emergency use authorization for coronavirus assays, bringing total to four (Bioanalysis Zone)
- COVID-19 labelled as a pandemic by WHO (ID Hub)
- The race for COVID-19 treatments and vaccines: February’s industry headlines (ID Hub)
- 2019-nCoV related to SARS-like coronaviruses of bat origin (ID Hub)
- COVID-19: stricter measures introduced across the globe (ID Hub)
Longer reads and insights
- Fighting coronavirus with MSCs: an interview with Ross Macdonald (RegMedNet)
- The economic impact of COVID-19 in Canada: a health economist’s perspective (ID Hub)
- Responding to COVID-19 with AI and machine learning (ID Hub)
- Coronavirus lockdown for bioanalysts: personal and professional challenges (Bioanalysis Zone)
- The effect of temperature fluctuations on the evolving coronavirus: speculations by Morteza Mahmoudi (The Nanomed Zone)
- ‘COVID Symptom Tracker’: an interview with SU2C CEO, Sung Poblete (Oncology Central)
- The importance of diagnostic testing for COVID-19 (ID Hub)
- Coronavirus: continued updates in basic research, vaccine development and testing (BioTechniques)
- COVID-19 vaccine developments (Bioanalysis Zone)
- COVID-19 is opening a door to a new era in drug development (Bioanalysis Zone)
- What role can the media play in managing the COVID-19 outbreak? (ID Hub)
- COVID-19: how the coronavirus spread globally (ID Hub)
- Eric Chen: imaging the atomic-resolution structure of coronavirus ‘spike’ protein (BioTechniques)
- COVID-19 testing: potential challenges and solutions (Bioanalysis Zone)
- The emergence and spread of the 2019 novel coronavirus (ID Hub)
- COVID-19 is opening a door to a new era in drug development (Bioanalysis Zone)
- On the (continued) hunt for a coronavirus vaccine (BioTechniques)
- COVID-19 low-cost and laboratory-safe detection protocol (Bioanalysis Zone)
- Coronavirus and bioanalysis: the fight against COVID-19 (Bioanalysis Zone)
- Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery (ID Hub)
- From wildlife to humans with the PREDICT project – an interview with Tracey Goldstein (ID Hub)
- Assessing the epidemic threat of viruses – candidates for the next pandemic (ID Hub)
Articles from the Future Science Group journal collection
Journal highlights
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Bersanelli M, 2020 – Imunotherapy - Drug repurposing strategies for COVID-19
Senanayake SL, 2020 – Future Drug Discovery - Membrane binding proteins of coronaviruses
Alsaadi and Jones, 2019 – Future Virology - Verification and diagnostic evaluation of the RealStar® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0
Hecht et al., 2019 – Future Microbiology - Engineering a novel endopeptidase based on SARS 3CLpro
Kuo et al., 2018 – BioTechniques - Post-translational modifications of coronavirus proteins: roles and function
Fung and Liu, 2018 – Future Virology
View the full collection of coronavirus-related journal articles here on BioTechniques – all articles are open access (page will be updated with all new articles as they are published)
Further resources
Many of Future Science Group’s specialized eCommunities are covering the COVID-19 pandemic from a range of perspectives, including 3D printing, bioanalysis and mental health. Find out more and discover our eCommunities below:
- 3DMedNet
- Bioanalysis Zone
- BioTechniques
- Nanomed Zone
- Neuro Central
- Oncology Central
- RegMedNet
- The Evidence Base®
